Form 4: ResMed Executive Sells Shares for Tax Withholding

Sentiment:

Insider Transaction Report 13 November 2025 2:23 PM

ResMed Global General Counsel Michael J. Rider reported multiple dispositions of common stock to cover tax obligations upon RSU vesting, alongside an ESPP purchase.

Summary

Michael J. Rider, Global General Counsel and Secretary of ResMed Inc., reported multiple transactions involving ResMed Common Stock.
On November 11, 2025, Rider disposed of a total of 1,525.024 shares (135.075 + 173.725 + 715.489 + 500.735) of ResMed Common Stock.
These dispositions were made to the issuer for tax withholding purposes upon the vesting of Restricted Stock Units (RSUs) granted on November 18, 2021, November 16, 2022, November 16, 2023, and November 20, 2024.
The price for these dispositions was $250.1 per share.
The reported beneficial ownership after these dispositions is 9,841 shares.
This beneficial ownership includes 38.9396 shares of ResMed stock purchased on October 31, 2025, through the ResMed Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions, primarily dispositions for tax withholding upon RSU vesting, which are expected events. The inclusion of an Employee Stock Purchase Plan acquisition adds a slightly positive note regarding continued executive investment.

Positives

The inclusion of 38.9396 shares purchased through the ResMed Employee Stock Purchase Plan on October 31, 2025, indicates continued investment by the executive in the company's equity.

Future Outlook

Management Comments

Michael J. Rider is identified as the Global General Counsel and Secretary of ResMed Inc.

Industry Context

Related Party Transactions

Dispositions of common stock were made to the issuer (ResMed Inc.) for tax withholding purposes upon the vesting of Restricted Stock Units, which is a standard compensation-related transaction between an executive and the company.

Stakeholder Impact

Shareholders: The transactions represent routine executive compensation activities, including RSU vesting and an Employee Stock Purchase Plan acquisition. There is no significant immediate impact on share price or company strategy.
Employees: The transactions reflect standard executive compensation practices, including RSU vesting and participation in an Employee Stock Purchase Plan.

Key Dates

Date	Description
11/18/2021	Grant date of Restricted Stock Units (RSUs) for which tax withholding occurred.
11/16/2022	Grant date of Restricted Stock Units (RSUs) for which tax withholding occurred.
11/16/2023	Grant date of Restricted Stock Units (RSUs) for which tax withholding occurred.
11/20/2024	Grant date of Restricted Stock Units (RSUs) for which tax withholding occurred.
10/31/2025	Date of purchase of 38.9396 shares through the ResMed Employee Stock Purchase Plan.
11/11/2025	Transaction date for all reported dispositions of common stock for tax withholding.
11/13/2025	Signature date of the reporting person.

Recommendation

hold

This Form 4 filing details routine insider transactions, specifically the disposition of shares for tax withholding upon RSU vesting and a small purchase through an Employee Stock Purchase Plan. These are standard compensation-related activities and do not provide new fundamental information about the company's operational performance or strategic direction. Therefore, a 'hold' recommendation is appropriate as there's no basis for a change in investment thesis based solely on this filing.

Keywords

ResMed, RMD, Form 4, Insider Trading, Stock Sale, RSU Vesting, Tax Withholding, Employee Stock Purchase Plan, Michael J. Rider

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.